This year, the FDA approved three drugs meant to prevent migraines and those, along with less expensive and less invasive techniques to stimulate the body’s response to pain through neurostimulation, are giving optimism to headache specialists and their patients after years of little progress.
from Kaiser Health News https://ift.tt/2zJIgSb
December 04, 2018
Rose
Health News, Kaiser Health News
No comments
Related Posts:
HHS Secretary Says Trump Wants To ‘Go Further’ Than Previous Plans To Tackle High Drug CostsPresident Donald Trump is expected to give a speech on drug pricing next week, but there have been few hints on any concrete ideas to lower drug prices. from Kaiser Health News https://ift.tt/2FEdKt5 … Read More
Trump’s Former Doctor Claims His Office Was ‘Raided’ — Is That Even Legal?The Associated Press takes a look at the laws surrounding medical records and patients' rights to obtain them. from Kaiser Health News https://ift.tt/2KwzBq1 … Read More
First-Of-Its-Kind Lawsuit Claims Pharma’s Role In Opioid Crisis Led To Higher Premiums For EveryoneThe industry is already defending itself against hundreds of lawsuits filed by cities and states, but this challenge takes a different route. “Insurance companies factored in the unwarranted and exorbitant healthcare costs of… Read More
Iowa House Passes 6-Week Abortion Ban Teeing Up An Aggressive Challenge To Roe V. WadeWith the so-called "heartbeat" bill, Republicans in the state shift away from the strategy of more incremental changes recently embraced by the anti-abortion movement. Instead, they have their eye on the Supreme Court and mid… Read More
First Edition: May 3, 2018Today's early morning highlights from the major news organizations. from Kaiser Health News https://ift.tt/2FCYLQh … Read More
Subscribe to:
Post Comments (Atom)
0 comments:
Post a Comment